Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

Siobhán B. Carr* (Corresponding Author), Elliot McClenaghan, Alexander Elbert, Albert Faro, Rebecca Cosgriff, Olzhas Abdrakhmanov, Keith Brownlee, Pierre Régis Burgel, Catherine A. Byrnes, Stephanie Y. Cheng, Carla Colombo, Harriet Corvol, Géraldine Daneau, Christopher H. Goss, Vincent Gulmans, Hector Gutierrez, Satenik Harutyunyan, Meagan Helmick, Andreas Jung, Nataliya KashirskayaEdward McKone, Joel Melo, Peter G. Middleton, Pedro Mondejar-Lopez, Isabelle de Monestrol, Lutz Nährlich, Rita Padoan, Megan Parker, M. Dolores Pastor-Vivero, Samar Rizvi, Rasa Ruseckaite, Marco Salvatore, Luiz Vicente R.F. da Silva-Filho, Nick Versmessen, Marco Zampoli, Bruce C. Marshall, Anne L. Stephenson, Scott C. Bell, David Reid, Peter Wark, Eva Van Braeckel, Sophie Gohy, Christiane Knoop, Jessica Pirson, Elke De Wachter, Lieven Dupont, Laurence Hanssens, Vicky Nowé, Monique Lequesne, Rodrigo A. Athanazio, CF Registry Global Collaboration, Owen Dempsey

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study'. Together they form a unique fingerprint.

Medicine & Life Sciences